Quantitation of Human Cells that Produce Neutrophils and Platelets in Vivo Obtained from Normal Donors Treated with Granulocyte Colony–Stimulating Factor and/or Plerixafor-Reference-Cited by-同舟云学术

Quantitation of Human Cells that Produce Neutrophils and Platelets in Vivo Obtained from Normal Donors Treated with Granulocyte Colony–Stimulating Factor and/or Plerixafor

Published:2016-11 Issue:11 Volume:22 Page:1945-1952
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Miller Paul H.,Nakamichi Naoto,Knapp David J.H.F.,Rabu Gabrielle,Schultz Kirk R.,Jones David M.,Couban Stephen,Eaves Connie J.^ORCID

Funder

Terry Fox Program

Canadian Institutes of Health Research (CIHR)

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference43 articles.

1. Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial;Powles;Lancet,2000

2. A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies;Couban;Blood,2002

3. Peripheral-blood stem cells versus bone marrow from unrelated donors;Anasetti;N Engl J Med,2012

4. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants;To;Bone Marrow Transplant,1992

5. Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma;Smith;J Clin Oncol,1997

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined G-CSF and Plerixafor enhance hematopoietic recovery of CD34+ cells from poor mobilizer patients in NSG mice;Experimental Hematology;2020-06

2. The case for plerixafor to replace filgrastim as the optimal agent to mobilize peripheral blood donors for allogeneic hematopoietic cell transplantation;Experimental Hematology;2019-02

3. Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD;Blood;2018-06-21